3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Uterine Cervical Neoplasms
3
Ganglioneuroblastoma
3
Vaginal Neoplasms
2
Neuroblastoma
2
Wilms Tumor
1
Thoracic Diseases
1
Testicular Neoplasms
1
Teratoma
1
Skin Neoplasms
1
Sarcoma, Ewing
1
Rhabdomyosarcoma
1
Recurrence
1
Pancreatic Neoplasms
1
Pancreatic Intraductal Neoplasms
1
Ovarian Germ Cell Cancer
1
Lung Neoplasms
1
Gliosarcoma
1
Glioma
1
Glioblastoma
1
Endodermal Sinus Tumor
1
Diffuse Intrinsic Pontine Glioma
1
Central Nervous System Neoplasms
1
Carcinoma, Renal Cell
1
Carcinoma, Endometrioid
1
Breast Neoplasms
1
Brain Neoplasms
1
Interventions
Hydroxyurea
3
Bevacizumab
3
pembrolizumab
2
Imatinib Mesylate
2
Everolimus
2
vistusertib
1
vatalanib
1
pasireotide
1
fludarabine phosphate
1
fludarabine
1
arginyllysine
1
antineoplaston AS 2-1
1
antineoplaston A10
1
aldesleukin
1
Whole Body Imaging
1
Verapamil
1
Sunitinib
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy, Image-Guided
1
Radiotherapy, Conformal
1
Radiotherapy
1
Radiosurgery
1
Proton Therapy
1
Nivolumab
1
Modafinil
1
Magnetic Resonance Spectroscopy
1
Ipilimumab
1
HDAC-42
1
Fentanyl
1
Erlotinib Hydrochloride
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Meningioma
×
Congresses as Topic
×
Clear all
No trials found.